MIAMI / Feb 27, 2024 / Business Wire / Ontrak Health (NASDAQ: OTRK), a leading AI-powered and telehealth-enabled healthcare company, has achieved a new milestone by introducing the Recovering Quality of Life Assessment (ReQoL) into its cutting-edge WholeHealth+ Product and Solutions Suite. This strategic advancement developed by the Oxford University Innovation Lab underscores Ontrak Health's commitment to transforming mental health care through continuous improvement, reinforcing its position as a leader in personalized and effective evidence-based solutions for mental health.
Recognizing the limitations of existing measures in assessing the quality of life for people with different mental health conditions, the development of ReQoL fills a critical need. ReQoL assessments can be used in healthcare and research settings to evaluate the impact of mental health conditions, psychological interventions, and healthcare interventions on patients' lives because they focus on understanding the person over the diagnosis, consistent with recovery strategies. Integrating this tool in Ontrak's coaching program emphasizes the commitment to measurement feedback in continually improving mental health care and outcomes.
Dr. Judith Feld, Chief Medical Officer at Ontrak Health, emphasized, "The integration of ReQoL aligns seamlessly with our commitment to delivering person-centric measurement-based care to people with mental health and substance use conditions. It's a testament to our dedication to innovation, blending clinical excellence with coaching feedback for durable outcomes."
As part of its thorough piloting and implementation of ReQoL, Ontrak Health has secured official recognition from the Oxford University Innovation Lab as an authorized licensee of this Clinical Outcomes Assessment (COA).
About Ontrak, Inc.
Ontrak, Inc. is a leading AI and telehealth-enabled healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. Ontrak identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. We engage individuals with anxiety, depression, substance use disorder and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. The company’s integrated intervention platform uses AI, predictive analytics and digital interfaces combined with dozens of care coach engagements to deliver improved member health, better healthcare system utilization, and durable outcomes and savings to healthcare payors.
Learn more at www.ontrakhealth.com
Last Trade: | US$1.44 |
Daily Change: | -0.02 -1.37 |
Daily Volume: | 17,045 |
Market Cap: | US$6.080M |
November 13, 2024 November 06, 2024 September 11, 2024 September 05, 2024 August 29, 2024 |
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB